On September 13, 2022, the ADSs were transferred from the Nasdaq Global Select Market to the Nasdaq Capital Market. The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Select Market, and companies on the Nasdaq Capital Market must meet certain financial and corporate governance requirements to qualify for continued listing. The ADSs continue to be listed and traded under the symbol “ORTX”. In connection with the transfer to the Nasdaq Capital Market, on October 4, 2022, Nasdaq granted the Company a second period of 180 days, or until April 3, 2023, to regain compliance with the minimum bid price requirement of $1.00 per share for a minimum of ten consecutive trading days. Nasdaq’s decision to approve the Company’s application to transfer to the Nasdaq Capital Market was based on the Company meeting the listing requirements of the Nasdaq Capital Market with the exception of the minimum bid requirement. The Company notified Nasdaq that it intended to cure the minimum bid price deficiency during the compliance period by implementing an adjustment to the Company’s ADS-to-ordinary share ratio, if necessary, prior to the expiration of the compliance period. The Company will continue to actively monitor its compliance with the minimum bid price requirement and will evaluate available options to regain compliance. If the Company fails to regain compliance during the additional compliance period, then Nasdaq will notify the Company of its determination to delist the Company’s ADSs, at which point the Company would have an opportunity to appeal the delisting determination to a Nasdaq Listing Qualifications Panel (the “Panel”), but there can be no assurance that the Panel would grant the Company’s request for continued listing.
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Frank Thomas Employment Agreement
As previously disclosed, on November 3, 2021, Frank Thomas, President and Chief Operating Officer of the Company, submitted his resignation and entered into a Transitional Services Agreement with the Company, which was subsequently amended on March 30, 2022 (as amended, the “Transitional Services Agreement”).
On October 4, 2022, the Company entered into an Amended and Restated Employment Agreement with Frank Thomas (the “Employment Agreement”), pursuant to which Mr. Thomas will continue to serve as President and Chief Operating Officer of the Company.
The Transitional Services Agreement was terminated concurrently with the parties’ entrance into the Employment Agreement. Among other things, the Employment Agreement provides that Mr. Thomas will receive a base salary of $528,000 per year and will be eligible for a target bonus of 50% of base salary. The Employment Agreement also provides that if Mr. Thomas terminates his employment for good reason or if the Company terminates his employment without cause (as “cause” and “good reason” are defined in the Employment Agreement), then upon his timely execution of a separation agreement containing, among other things, a general release of claims, (i) Mr. Thomas will receive an amount equal to 12 months of his current base salary, (ii) Mr. Thomas will receive the previous year’s bonus amount if not already paid and to the extent it otherwise would have been earned, (iii) for up to 12 months, the Company will pay the monthly employer COBRA premium for the same level of group health coverage as in effect at the conclusion of Mr. Thomas’s employment and (iv) the Company shall pay up to $20,000 to an outplacement services provider to provide outplacement services to Mr. Thomas or, in lieu of such services, Mr. Thomas may choose to receive a payment in the amount of $15,000. The Employment Agreement further provides that in the event Mr. Thomas terminates his employment for good reason or if the Company terminates his employment without cause, in either case within 12 months following a change in control (as defined in the Employment Agreement), then upon his timely execution of a separation agreement containing, among other things, a general release of claims, in lieu of the severance benefits described in the preceding sentence, (i) Mr. Thomas will receive an amount equal to 12 months of his current base salary plus the amount of his target bonus, (ii) Mr. Thomas’s stock options and other stock-based awards shall immediately accelerate and become fully exercisable or nonforfeitable, (iii) for up to 12 months, the Company will pay the monthly employer COBRA premium for the same level of group health coverage as in effect at the conclusion of Mr. Thomas’s employment and (iv) the Company shall pay up to $20,000 to an outplacement services provider to provide outplacement services to Mr. Thomas or, in lieu of such services, Mr. Thomas may choose to receive a payment in the amount of $15,000.
The foregoing description of the Employment Agreement is not complete and is qualified in its entirety by reference to the full text of the Employment Agreement, a copy of which is filed herewith as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Option Repricing
On October 4, 2022, the Company’s Compensation Committee of the Board of Directors (the “Compensation Committee”) approved the repricing of all stock options granted under the Company’s 2018 Share Option and Incentive Plan and held by current employees with an exercise price per share greater than $1.25 (“Eligible Stock Options”). In approving the repricing, the Compensation Committee considered the impact of the current exercise prices of outstanding stock options on the incentives provided to employees, the lack of retention value provided by the outstanding stock options to employees, and the impact of such options on the capital structure of the Company.
As a result of the repricing, the exercise price of the Eligible Stock Options will now have an exercise price of $0.58 per share, which equals the closing price of the ADSs at close of market on October 4, 2022 plus 15%. Bobby Gaspar, Chief Executive Officer of the Company, and Frank Thomas, President and Chief Operating Officer of the Company, hold 1,455,006 and 1,398,145 Eligible Stock Options, respectively, subject to the repricing. Stock options held by non-employee directors of the Company’s Board of Directors were not included in the repricing. Except for the modified exercise price, all other terms and conditions of each of the Eligible Stock Options remain in full force and effect.
